United Kingdom

Post-Brexit, the UK is poised to become a global biosimilars hotspot

Regulatory developments and changing attitudes at the courts make the country an increasingly attractive jurisdiction in which to launch products

Post-Brexit, the UK is poised to become a global biosimilars hotspot
Wireless back to the fore for IP Bridge in multi-jurisdiction patent tangle with Huawei
11 May 2021

Wireless back to the fore for IP Bridge in multi-jurisdiction patent tangle with Huawei

Japanese fund’s first acquisition and first new litigation since going private have both centred on SEPs

New report lays bare the worrying extent of the UK's IP malaise
3 May 2021

New report lays bare the worrying extent of the UK's IP malaise

British companies lag their competitors on a number of measures, as well as on business investment in R&D, according to research published today

Latest

View all
27 May 2021

United Kingdom – clouded in uncertainty

Read more

28 Apr 2021

Why comparable licences are key in the biggest SEP battles

The Long Read: The Patents Court in the UK has seen more than its fair share of precedent-busting FRAND cases in recent years. EIP’s Tom Brazier takes a scalpel to three of the biggest to tease out how litigants can secure disclosure of the kind of commercially sensitive information that will set them up for courtroom success Read more

19 Apr 2021

European Super League could face domain and trademark issues as backlash to football revolution grows

Analysis by the team at IAM's sister publication World Trademark Review finds the 12 clubs involved are IP-savvy, but vulnerable to brand risk Read more

24 Mar 2021

In latest litigation play, Ocado looks for quick leverage in rival’s largest market

Pair of suits filed in Mannheim and Munich accuses AutoStore of infringing two utility models and raises prospect of a sales ban Read more

Designs

View all
5 Oct 2020

Arm’s patents will help Nvidia in many of the world’s high-growth industries

The proposed tie-up would significantly improve the US company’s IP cover in a number of key areas – but would not come consequence free Read more

10 Aug 2019

A No Deal Brexit now looks unavoidable, so plan accordingly

Boris Johnson becoming Prime Minister has totally changed the trajectory of the UK's departure from the EU and IP owners' strategies should reflect that Read more

3 Jul 2019

Law firm’s patent attorney deal shows changing face of IP practice in the UK

Lewis Silkin’s acquisition of Ablett & Stebbing is a first and demonstrates just how far things have moved in a once conservative market Read more

3 Jun 2019

Deloitte makes major IP play with acquisition of top advisory

Big Four firm closes deal to acquire UK-based ClearView in a further sign that IP value creation is moving to the centre of the corporate agenda Read more

Finance

View all
18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

6 May 2020

UK parliament committee warned on China’s plans for Imagination Technologies

Imagination owner explains that licensing IP is not the same as transferring it, but freshly resigned CEO claims that only diligent management oversight can prevent key trade secret loss Read more

15 Apr 2020

Looking for IP value in a time of economic shock

Patents, know-how and data, as well as other intellectual assets, are all very interesting opportunities right now - if you know what you are doing Read more

7 Apr 2020

Chinese investors spark IP fears with plans for British chip firm

UK government called on to investigate as Chinese backer moves to take up board seats, but the time to worry about IP ownership may be past Read more

Frand/SEPS

View all
4 Dec 2020

Chinese court to set global FRAND rate in Oppo-Sharp dispute

Oppo’s major win at the Shenzhen Intermediate People’s Court signifies that China is ready to have a bigger say on global SEP disputes Read more

4 Nov 2020

A blissful summer for SEP owners

The licensing community had much to enjoy over the summer months, from key court decisions in the United States and Europe to positive policy developments Read more

4 Nov 2020

As the dust settles after Unwired Planet, what next?

SEP owners and implementers around the world continue to pick through the nuances of the UK Supreme Court’s landmark decision in an attempt to scope out the route ahead Read more

4 Nov 2020

Roundtable: Essential reading

SEPs were never far from the headlines in Summer 2020. Experts discuss some of the most Read more

Law & Policy

View all
3 Mar 2021

UK court clarifies when patents can be used without owner authorisation for “the service of the crown”

Concerns that rarely deployed Crown Use might become more commonplace have been significantly alleviated after appeals judges deliver ruling in IPCom v Vodafone Read more

12 Feb 2021

No UK withdrawal from the EPO despite plan to join CPTPP, says government spokesperson

The apparent incompatibility in grace period provisions between the two agreements not seen as an obstacle to membership of both Read more

4 Feb 2021

UK plan to join CPTPP raises questions about European Patent Organisation membership

On the face of it, the Comprehensive and Permissive Trans Pacific Partnership’s provisions on the grace period run contrary to those that apply in the EPC Read more

3 Feb 2021

Recent judicial appointments ensure UK remains safe pair of hands for IP disputes

The selection of James Mellor QC and Richard Meade QC as judges to sit in the Patents Court will help to calm jitters over the exit several specialists Read more

Litigation

View all
3 Mar 2021

UK court clarifies when patents can be used without owner authorisation for “the service of the crown”

Concerns that rarely deployed Crown Use might become more commonplace have been significantly alleviated after appeals judges deliver ruling in IPCom v Vodafone Read more

18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

3 Feb 2021

Ocado steps up US patent fight with claims of PTO fraud against rival

The UK online retailer is in an increasingly bitter dispute over robot technology and has accused AutoStore of “serious abuses of the patenting process” Read more

3 Feb 2021

Recent judicial appointments ensure UK remains safe pair of hands for IP disputes

The selection of James Mellor QC and Richard Meade QC as judges to sit in the Patents Court will help to calm jitters over the exit several specialists Read more

Market Developments

View all
17 Dec 2020

What you need to know about post-Brexit changes to the UK’s SPC system

Failures to update IP management following the New Year could be costly for life sciences businesses Read more

4 Dec 2020

Chinese court to set global FRAND rate in Oppo-Sharp dispute

Oppo’s major win at the Shenzhen Intermediate People’s Court signifies that China is ready to have a bigger say on global SEP disputes Read more

27 Nov 2020

Do not expect an electronic vehicle patent boom in the UK despite 2030’s petrol and diesel car sales ban

Plans announced by British Prime Minister Boris Johnson will not change the IP reality, which is that Germany is the only serious game in town for auto in Europe Read more

10 Nov 2020

There has never been a better time to sell or buy drug royalties, says industry veteran

IAM speaks to leading deal-maker David MacNaughtan about his new fund and the growth of this form of life sciences IP monetisation Read more

Non-Practising Entities

View all
18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

15 Feb 2021

Open Invention Network adds major banks to membership with Barclays and TD Bank sign-ups

Risk from rivals, threats from patent assertion entities and the widespread adoption of open source software is increasing financial institutions’ interest in defensive networks, says OIN CEO Read more

4 Dec 2020

Chinese court to set global FRAND rate in Oppo-Sharp dispute

Oppo’s major win at the Shenzhen Intermediate People’s Court signifies that China is ready to have a bigger say on global SEP disputes Read more

10 Nov 2020

There has never been a better time to sell or buy drug royalties, says industry veteran

IAM speaks to leading deal-maker David MacNaughtan about his new fund and the growth of this form of life sciences IP monetisation Read more

Patent Pools

View all
20 Jul 2020

After success of early stage covid-19 vaccine trial, Oxford University's coronavirus IP policy explained

With the promising news today that a coronavirus vaccine being developed by scientists at the university is safe and triggers an immune response, we revisit our exclusive April interview with the head of Oxford's tech transfer office in which he talks about its new, expedited, approach to granting covid-related licences Read more

4 Mar 2020

The top 10 patent market developments of 2019

Asset sales, trade wars and new names at the top made last year transformative for IP owners. Read more

16 Dec 2019

Xiaomi seeks Sisvel FRAND rate in Beijing

Chinese smartphone maker follows an increasingly popular playbook, setting up another contest for jurisdiction between European and Chinese courts Read more

30 Aug 2019

IP market news highlights

Some of the major news stories carried on the IAM platform in June and July Read more

Patents Law

View all
4 Mar 2021

German and UK IP firms dominate top EPO representative list for 2020

Hoffmann Eitle filed more applications on behalf of clients than anyone else last year, followed by Grünecker and Dehns Read more

3 Mar 2021

UK court clarifies when patents can be used without owner authorisation for “the service of the crown”

Concerns that rarely deployed Crown Use might become more commonplace have been significantly alleviated after appeals judges deliver ruling in IPCom v Vodafone Read more

23 Feb 2021

How hub-and-spoke businesses are creating new pharma IP monetisation models

The launch of Centessa is the latest development in a trend that has big implications for the monetisation of unpartnered or deprioritised IP-backed pharma assets Read more

18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

Strategy

View all
23 Feb 2021

How hub-and-spoke businesses are creating new pharma IP monetisation models

The launch of Centessa is the latest development in a trend that has big implications for the monetisation of unpartnered or deprioritised IP-backed pharma assets Read more

28 Jan 2021

Fears over UK sufficiency rules are tempered by new court decision

There had been some concerns about the regime following the Supreme Court Regeneron judgment but a recent case has clarified the situation Read more

17 Dec 2020

What you need to know about post-Brexit changes to the UK’s SPC system

Failures to update IP management following the New Year could be costly for life sciences businesses Read more

4 Dec 2020

Chinese court to set global FRAND rate in Oppo-Sharp dispute

Oppo’s major win at the Shenzhen Intermediate People’s Court signifies that China is ready to have a bigger say on global SEP disputes Read more

Technology Licensing

View all
23 Feb 2021

How hub-and-spoke businesses are creating new pharma IP monetisation models

The launch of Centessa is the latest development in a trend that has big implications for the monetisation of unpartnered or deprioritised IP-backed pharma assets Read more

19 Feb 2021

Dialog’s patents will boost Renesas’ fast growing licensing business

The purchase of the UK chipmaker will contribute to the monetisation programme’s potential, particularly within circuit technologies Read more

9 Feb 2021

Five IP takeaways from Jazz Pharmaceuticals’ $7 billion medical cannabis buyout

A major milestone in the medical cannabinoid patent market has been passed Read more

10 Nov 2020

There has never been a better time to sell or buy drug royalties, says industry veteran

IAM speaks to leading deal-maker David MacNaughtan about his new fund and the growth of this form of life sciences IP monetisation Read more

Trade Secrets

View all
18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

21 Aug 2020

Countries that seek to lead in AI must think seriously about how to use IP to protect what it creates

Exclusive article for IAM written by Professor Ryan Abbott, one of the team behind the groundbreaking DABUS patent applications Read more

17 Aug 2020

US company secures injunction against Chinese rival in UK trade secrets case

Dispute between an American plaintiff and a Shenzhen-based defendant, involving alleged theft of IP in China, sees London court making preliminary grant Read more

13 Aug 2020

It’s not all bad news for biopharma IP monetisation during coronavirus slowdown

Oncology licensing, smaller acquisitions and abundant venture capital provide means of commercialising innovation during M&A decline Read more

Valuation

View all
18 Feb 2021

Seven top IP tips for biotech SMEs

How smaller biotechs can best overcome pitfalls and maximise the value of their inventions Read more

9 Feb 2021

Five IP takeaways from Jazz Pharmaceuticals’ $7 billion medical cannabis buyout

A major milestone in the medical cannabinoid patent market has been passed Read more

10 Nov 2020

There has never been a better time to sell or buy drug royalties, says industry veteran

IAM speaks to leading deal-maker David MacNaughtan about his new fund and the growth of this form of life sciences IP monetisation Read more

27 Aug 2020

Translational research key to realising value of university IP, says UCL biopharma chief

Dr Richard Fagan of University College London Business tells IAM about the process of turning patents for early-stage research into investable assets Read more

Find an expert